IgM/IgA nephropathy in callitrichids: Antigen studies

Nephron

Volumn 82, Issue 3, 1999, Pages 221-231

  Brack, M ^a,b   Schroeder, C ^a   Fooke, M ^a   Schlumberger, W ^a  

^a GERMAN PRIMATE CENTER   (Germany)

^b Deutsches Primatenzentrum   (Germany)

Author keywords

Gliadin; IgM IgA nephropathy; Mesangioproliferative nephropathy; Nutritive antigens

Indexed keywords

ANTIGEN; EGG PROTEIN; GLIADIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY PARENCHYMA; MARMOSET; MILK; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SERUM;

ANIMALS; ANTIGENS; CALLITRICHINAE; FOOD; GLIADIN; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; KIDNEY; MONKEY DISEASES; RHEUMATOID FACTOR;

EID: 0033029898     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045406     Document Type: Article

References (97)

1. Brack M: IgM-mesangial nephropathy in callitrichids. Vet Pathol 1988;25:270-276.
2. Brack M: IgM-mesangial nephropathy in Callitrichidae. Primate Rep 1989;24:43-56.
3. Brack M: IgM-Nephropathie (-Nephritis) bei Krallenaffen (Primaten, Anthropoidea, Platyrrhinii, Callitrichidae). J Vet Med 1990;37:692-707.
4. Nadashi T, Silva FG, Hogg RJ: Minimal change nephrotic syndrome-focal sclerosis complex (including IgM nephropathy and diffuse mesangial hypercellularity); in Tisher CC, Brenner BM (eds): Renal Pathology: With Clinical and Functional Correlation, ed 2. Philadelphia, Lippincott, 1994, vol 1, pp 330-389.
5. Brack M: Callitrichid IgM nephropathy - an old age-related disease? Lab Anim 1995;29:54-58.
6. Brack M, Weber M: Ultrastructural and histochemical mesangial alterations in Callitrichid IgM nephropathy (primates: platyrrhina). Nephron 1995;69:286-292.
7. Brack M, Fooke M: Circulating IgM in callitrichid IgM nephropathy. Primate Rep 1991;30:9-15.
8. Bhasin HK, Abuello JG, Nayak R, Esparza AR: Mesangial proliferative glomerulonephritis. Lab Invest 1978;39:21-29.
9. Cohen AH, Border WA, Glassock R: Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Invest 1978;38:610-619.
10. Berger J, Hinglais N: Les dépôts intercapillaires d'IgA-IgG. J Urol Néphrol 1968;74:694-695.
11. Hughson MD, Megill DM, Smith SM, Tung KSK, Miller G, Hoy WE: Mesangiopathic glomerulonephritis in Zuni (New Mexico) Indians. Arch Pathol Lab Med 1989;113:148-157.
12. Smith SM, Hoy WE, Pathak D, Megill DM, Tung KS, Hughson MD: Pathologic findings in mesangiopathic glomerulonephritis in Navajo Indians. Arch Pathol Lab Med 1989;113:158-163.
13. Nomoto Y, Suga T, Miura M, Nomoto H, Tomino Y, Sakai H: Characterization of an acidic nuclear protein recognized by autoantibodies in sera from patients with IgA nephropathy. Clin Exp Immunol 1986;65:513-519.
14. Nagy J, Scott H, Brandtzaeg P: Antibodies to dietary antigens in IgA nephropathy. Clin Nephrol 1988;29:275-279.
15. Sato M, Kojima H, Takayama K, Koshikawa S: Glomerular deposition of food antigens in IgA nephropathy. Clin Exp Immunol 1988;73:295-299.
16. Yap HK, Sakai RS, Bahn L, Rappaport V, Woo KT, Ananthuraman V, Lim CH, Chiang GSC, Jordan S: Anti-vascular endothelial cell antibodies in patients with IgA nephropathy: Frequency and clinical significance. Clin Immunol Immunopathol 1988;49:450-462.
17. Jackson S, Moldoveanu Z, Krik KA, Julian BA, Patterson TF, Mullins AL, Jilling T, Mestecky J, Galla JH: IgA-containing immune complexes after challenge with food antigens in patients with IgA nephropathy. Clin Exp Immunol 1992;89:315-320.
18. Westermeier R: SDS-Polyacrylamidelektrophore; in Westermeier R (ed): Elektrophoresepraktikum. Weinheim, Verlag Chemie, 1990, p 180.
19. Chorzelski TP, Beutner EH, Sulej J, Tchorzewska H, Jablonska S, Kumar V, Kapuscinska A: IgA anti-endomysium antibody: A new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol 1984;111:395-402.
20. Czerkinsky C, Koopman WJ, Jackson S, Collins E, Crago SS, Schrohenloher RE, Julian BA, Galla JH, Mestecky J: Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest 1986;77:1931-1938.
21. Sinico RA, Formasieri A, Oreni N, Benuzzi S, D'Amico G: Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease). J Immunol 1986;137:536-541.
22. Lachmann PJ, Müller-Eberhardt HJ: The demonstration in human serum of 'conglutinogen activating factor' and its effect on the third component. J Immunol 1968;100:691-698.
23. D'Amico G, Imbasciati E, di Belgioioso GB, Bertoli S, Fogazzi G, Ferrario F, Fellin G, Ragni A, Colasanti G, Minetti L, Ponticelli C: Idiopathic IgA mesangial nephropathy. Medicine (Baltimore) 1985;64:49-60.
24. Bene MC, Faure GC: Composition of mesangial deposits in IgA nephropathy: Complement factors. Nephron 1987;46:219.
25. Iijima K, Yoshikawa N, Shiozawa S, Matsuyama S, Kobayashi K, Yoshiya K, Nakamura H: Immune abnormalities and clinical course in childhood IgA nephropathy. Nephron 1990;56:255-260.
26. Mustonen JT, Rantala IS, Helin HJ, Pasternack AI: IgA-IgM nephropathy: A subgroup of primary mesangial glomerulonephritis. Am J Clin Pathol 1991;95:863-866.
27. Faedda R, Pirisi M, Satta A, Bosincu L, Bartoli E: Immuno-suppressive treatment of Berger's disease. Clin Pharmacol Ther 1966;60:561-567.
28. Suzuki S, Gejyo F, Nakatomi Y, Odani S, Sato H, Arakawa M: Role of IgA, IgG and IgM antibodies against Haemophilus parainfluenzae antigens in IgA nephropathy. Clin Nephrol 1995;46:287-295.
29. D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987;64:709-727.
30. Fornasieri A, Pinerolo C, Bernasconi P, Li M, Armelloni S, Gibelli A, D'Amico G: Anti-mesangial and anti-endothelial cell antibodies in IgA mesangial nephropathy. Clin Nephrol 1995;44:71-78.
31. Yoshiara S, Yoshikawa N, Matsuo T: Immunoelectron microscopic study of childhood IgA nephropathy and Henoch-Schönlein nephritis. Virchows Arch A Pathol Anat Histopathol 1987;412:95-102.
32. Yoshikawa N, Iijima K, Maehara K, Yoshiara S, Yoshita K, Matsuo T, Okada S: Mesangial changes in IgA nephropathy in children. Kidney Int 1987;32:585-589.
33. Sessa A, Meroni M, Battini G, Congalonieri R, Radaelli L, Torri-Tarelli L: Berger's disease without IgA deposits? Nephron 1989;51:436-437.
34. Lomax-Smith JD, Zabrowarny LA, Howart GS, Seymoud AE, Woodroffe AJ: The immunochemical characterization of mesangial IgA deposits. Am J Pathol 1983;113:359-364.
35. Valentijn RM, Radl J, Haaijman JJ, Vermeer BJ, Weening JJ, Kaufmann RH, Daha MR, van Es LA: Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int 1984;26:760-766.
36. Lai K-N, Chan KW, MacMoune F, Ho CP, Van KW, Lam CWK, Vallance-Owen J: The immunochemical characterization of the light chains in the mesangial IgA deposits in IgA nephropathy. Am J Clin Pathol 1986;85:548-551.
37. Ballardie PW, Brenchley PE, Williams S, O'Donoghue DJ. Autoimmunity in IgA nephropathy. Lancet 1988;ii:588-591.
38. Van den Wall Bake AWL, Daha MR, van der Ark A, Hiemstra PS, Radl J, van Es LA: Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy. Clin Exp Immunol 1988;74:115-120.
39. Van den Wall Bake AWL, Daha MR, Jaaijman JJ, Radl J, van der Ark A, van Es LA: Elevated production of polymeric and monomeric IgA 1 by the bone marrow in IgA nephropathy. Kidney Int 1989;35:1400-1404.
40. Suzuki S, Kobayashi H, Sato H, Arakawa M: Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy. Clin Nephrol 1990;33:66-71.
41. Mole CM, Renoult E, Béné MC, Seilles E, Kessler M, Revillard JP, Faure GC: Serum secretory IgA and IgM and free secretory component in IgA nephropathy. Nephron 1995;71:75-78.
42. Reterink TJF, Schroeijers WEM, van Es LA, Daha MR: Dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human renal mesangial cells. Mediat Inflamm 1996;5:191-195.
43. Allen A, Harper S, Feehally J: Origin and structure of pathogenic IgA in IgA nephropathy. Biochem Soc Trans 1997;25:486-490.
44. Hene RJ, Schuurman H-J, Kater L: Immunoglobulin A subclass-containing plasma cells in the jejunum in primary IgA nephropathy and in Henoch-Schönlein purpura. Nephron 1988;48:4-7.
45. Wilson CB: Immunopathogenesis of kidney disease; in Zabriskie JB, Fillit H, Villareal H Jr, Becker EL (eds): Clinical Immunology of the Kidney. New York, Wiley & Sons, 1982, pp 27-76.
46. Parai SK, Ghose T: IgA nephropathy in adults: Immunohistologic findings and clinical course. Can Med Assoc J 1985;132:1381-1384.
47. Yoshizawa N, McClung JA, Ohshima S, Takahashi K, Treser G: IgA nephropathy occurring in the context of previous acute glomerulonephritis. Nephron 1986;44:167-173.
48. Coppo R, Basolo B, Piccoli G, Mazzucco G, Bulzomi MR, Roccatello D, de Marchi M, Carbonara AO, di Belgiojoso GB: IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis. Clin Exp Immunol 1984;57:583-590.
49. Julian BA, Waldo FB, Rifai A, Mestecky J: IgA nephropathy, the most common glomerulonephritis worldwide: A neglected disease in the United States. Am J Med 1988;84;129-132.
50. Tomino Y, Yagame M, Eguchi K, Miyazaki M, Nomoto Y, Sakai H, Shirato I, Ho K: Detection of anionic sites and immunoglobulin A deposits in the glomerular capillary walls from patients with IgA nephropathy. J Clin Lab Anal 1989;3:101-107.
51. Welsh TR, Beischel LS, Choi EM: Molecular genetics of C4B deficiency in IgA nephropathy. Hum Immunol 1989;26:353-363.
52. Woodrow DF, Shore I, Moss I, Gower P, Philips M: Immunoelectron microscopic studies of immune complex deposits and basement membrane components in IgA nephropathy. J Pathol 1989;157:47-57.
53. Zwirner J, Burg M, Schulze M, Brunkhorst R, Götze O, Koch K-M, Floege J: Activated complement C3: A potentially novel predictor of progressive IgA nephropathy. Kidney Int 1997;51:1257-1264.
54. Fornasieri A, Sinico RA, Maldifassi A, Bernasconi P, Vegni M, D'Amico G: IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease). Br Med J 1987;295:78-80.
55. Sinico RA, Fornasieri A, Maldifassi P, Colasanti A, D'Amico G: The clinical significance of IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease). Clin Nephrol 1988;30:182-186.
56. Nakano M, Ueno M, Nishi S, Suzuki S, Hasegawa H, Watanabe T, Kuroda T, Ito S, Arakawa M: Determination of IgA and IgM rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy. Ann Rheum Dis 1996;55:520-524.
57. Masuda Y, Terazawa K, Kawakami S, Ogura Y, Sugiyama N: Clinical and immunological study of IgA nephropathy before and after tonsillectomy. Acta Otolaryngol (Stockh) 1988 (suppl 454):248-255.
58. Dueymes M, Mignon-Conte M, Dueymes JM, Vernier I, Conte JJ: Mesangial staining with cytomegalovirus antibodies in IgA nephropathy. Lancet 1989;i:619.
59. Waldo FB, Britt WJ, Tomana M, Julian BA, Mestecki J: Non-specific mesangial staining with antibodies against cytomegalovirus in immunoglobulin A nephropathy. Lancet 1989;i:129-131.
60. Coppo R, Basolo B, Rollino C, Roccatello D, Martina G, Amore A, Piccoli G: Dietary gluten and primary IgA nephropathy. N Engl J Med 1986;315:1167-1168.
61. Coppo R, Roccatello D, Amore A, Quattrococchio G, Molino A, Gianoglio B, Amoroso A, Bajardi P, Piccoli G: Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol 1990;33:72-86.
62. Rostoker G, Laurent J, Andre C, Cholin S, Lagrue G: High levels of IgA antigliadin antibodies in patients who have IgA mesangial glomerulonephritis but not coeliac disease (abstract). Lancet 1988;i:356-357.
63. Rostoker G, Delprato S, Petit-Phar M, Ben Maadi A, Laurent J, Lang P, Weil B, Lagrue G: IgA antigliadin antibodies as a possible marker for IgA mesangial glomerulonephritis in adults with primary glomerulonephritis. N Engl J Med 1989;320:1283-1284.
64. Murakami T, Kawakami H: Questionable role of soy protein in childhood IgA nephropathy. Nephron 1993;64:395-398.
65. Hinoshita F, Suzuki Y, Yokoyama K, Hara S, Yamada A, Ogura Y, Hashimoto H, Tomura S, Marumo F, Ueno Y: Experimental IgA nephropathy induced by a low-dose environmental mycotoxin, nivalenol. Nephron 1997;75:469-478.
66. Rostoker G, André C, Branellec A, Bourhala S, Laurent J, Lagrue G: Lack of antireticulin and IgA antiendomysium antibodies in sera of patients with primary IgA nephropathy associated with circulating IgA antibodies to gliadin. Nephron 1988;48:81.
67. Cederholm B, Wieslander J, Bygren P, Heinegard D: Patients with IgA nephropathy have circulating anti-basement membrane antibodies reacting with structures common to collagen I, II and IV. Proc Natl Acad Sci USA 1986;83:6151-6155.
68. Lawler W, Williams G, Tarpey P, Mallick NP: IgM associated primary diffuse mesangial proliferative glomerulonephritis. J Clin Pathol 1980;33:1029-1038.
69. Hirszel P, Yamase H, Carney WR, Galen MA, Graeber CW, Johnson KJ, Kennedy TL, Lapkin RA, McLean RH, Rosenworcel E, Rowett DA: Mesangial proliferative glomerulonephritis with IgM deposits. Nephron 1984;38:100-108.
70. Hsu H-C, Chen W-Y, Lin G-J, Chen L, Kao S-L, Huang C-C, Lin C-Y: Clinical and immunopathologic study of mesangial IgM nephropathy: Report of 41 cases. Histopathology 1984;8:435-446.
71. O'Donoghue DJ, Lawler W, Hunt LP, Acheson EJ, Mallick NP: IgM-associated primary diffuse mesangial proliferative glomerulonephritis: Natural history and prognostic indicators. Q J Med 1991;79:333-350.
72. Al-Eisa A, Carter JE, Lirenman DS, Magil AB: Childhood IgM nephropathy: Comparison with minimal-change disease. Nephron 1996;72:37-43.
73. Gonzalo A, Mampaso F, Gallego N, Quereda C, Fierro C, Ortuño J: Clinical significance of IgM mesangial deposits in the nephrotic syndrome. Nephron 1985;41:246-249.
74. Chen W-P, Lin C-Y: Augmented expression of interleukin-6 and interleukin-1 genes in the mesangium of IgM mesangial nephropathy. Nephron 1994;27:281-284.
75. Di Sciullo SO, Abuelo JG, Moalli K, Pezzullo JC: Circulating heavy IgM in IgM nephropathy. Clin Exp Immunol 1988;73:395-400.
76. Thomsen OF, Ladeford J: Glomerular tip lesions in renal biopsies with focal-segmental IgM. APMIS 1991;99:836-843.
77. Del Moral RG, Gomez-Morales M, Cortex V, Aguayo ML, Gigosos RL, Lardelli P, Navas A, Aneiros J, Aguilar D: Mononuclear cell subsets in IgM mesangial proliferative glomerulonephritis. Nephron 1993;65:215-221.
78. Lin C-Y, Chu CM: Studies of circulating immune complexes and lymphocyte subpopulation in childhood IgM mesangial nephropathy. Nephron 1986;44:198-203.
79. Pollet S, Depner T, Moore P, Olander H, Robbins D: Mesangial glomerulopathy and IgM rheumatoid factor in rheumatoid arthritis. Nephron 1989;51:107-111.
80. Endoh M, Suga T, Sakai H: IgG/IgA and IgM rheumatoid factors in patients with glomerulonephritis. Nephron 1985;39:330-335.
81. Hoy WE, Megill DM: End-stage renal disease in southwestern native Americans, with special focus on the Zuni and Navajo Indians. Transplant Proc 1989;21:3906-3908.
82. Hoy WE, Smith SM, Hughson MD, Megill DM: Mesangial proliferative glomerulonephritis in southwestern American Indians. Transplant Proc 1989;21:3909-3912.
83. Megill DM, Hoy WE: Risk factors for renal disease in a native American community. Transplant Proc 1989;21:3902-3905.
84. Feehally J: IgA nephropathy - a disorder of IgA production? Q J Med 1997;90:387-390.
85. Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S: Defective galactosylation and clearance of IgAl molecules as a possible etiopathogenic factor in IgA nephropathy; in Béné MC, Faure G, Kessler M (eds): IgA Nephropathy: The 25th Year. Contrib Nephrol. Basel, Karger, 1993, vol 104, pp 172-182.
86. Alvarado CG, Cotterell AH, Parker W, Logan JS, Platt JL: Variation in expression of biologically reactive xenoantigen does not correlate with expression of Galα(1-3)Gal. Transplant Proc 1996;28:855.
87. Galili U, Gregory CR, Morris RE: New World monkeys as a primate model for xenografts in the absence of anti-gal. Transplant Proc 1996;28:567-568.
88. Caton JM, Hill DM, Hume ID, Crook GA: The digestive strategy of the common marmoset, Callithrix jacchus. Comp Biochem Physiol [A] 1996;114:1-8.
89. Egler SG: Hábitos alimentares de Saguinus bicolor bicolor (Primates, Callitrichidae) na região de Manaus, Amazonas. Primatol Brasil 1991;3:213-214.
90. Scanlon CE, Adélio M, Monteiro da Cruz P, Rylands AB: Exploracão de vegetais pelo saguicomun, Callithrix jacchus. Primatol Brasil 1991;3:197-205.
91. Roitt I, Brostoff J, Male D: Immunology. St. Louis, Mosby, 1985.
92. Sacks SH, Zhou W, Andrews PA, Hartley B: Endogenous complement C3 synthesis in immune complex nephritis. Lancet 1993;342:1273-1274.
93. Goujet-Zalc C, Ripoche J, Guercy A, Mahouy G. Fontaine M: Marmoset red blood cell receptor for membrane-associated complement components is not related to human CR1: Partial characterization of the C3-binding proteins responsible for the spontaneous rosette formation between marmoset red blood cells and human leukocytes. Cell Immunol 1987;109:282-294.
94. Weiner EM: On the interaction of the first complement component C1 and its subunit C1q with solid-phase IgM immune complexes. Scand J Immunol 1988;28:425-430.
95. Takahashi M, Tack BF, Nussenzweig V: Requirements for the solubilization of immune aggregates by complement: Assembly of a factor B-dependent C3 convertase on the immune complexes. J Exp Med 1977;145:86-100.
96. Schena PF, Pastore A, Sinico RA, Montinaro V, Fornasieri A: Polymeric IgA and IgA rheumatoid factor decrease the capacity of serum to solubilize circulating immune complexes in patients with primary IgA nephropathy. J Immunol 1988;141:125-130.
97. Zwirner J, Felber E, Burger R, Bitter-Suermann D, Riethmüller G: Classical pathway of complement activation in mammalian kidneys. Immunology 1993;80:162-167.